               SEQUENCE LISTING

<110> DEBIOPHARM RESEARCH & MANUFACTURING S.A.
<120> Reactive conjugates

<130> 228970

<160> 3
<170> BiSSAP 1.3.6

<210> 1
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> peptide portion of compound, as shown in formula (8a) of the application

<220> 
<221> MOD_RES
<222> (1)..(1)
<223> P-Y-S as defined in item 1

<220> 
<221> VARIANT
<222> (1)..(1)
<223> represents an amino acid, a dicarboxylic acid, or a peptide moiety represented by formula (9a) on p. 16 of the application

<220>
<221> DISULFID
<222> (2)..(12)
<223>

<220> 
<221> VARIANT
<222> (4)..(8)
<223> Each independently represent an amino acid

<220> 
<221> VARIANT
<222> (13)..(13)
<223> Represents an amino acid, or a peptide moiety represented by formula (9b) on p. 17 of the application

<220> 
<221> VARIANT
<222> (14)..(14)
<223> Represents a single covalent bond, or a trifunctional amino acid such as diamino-carboxylic acid 
         
<220> 
<221> MOD_RES
<222> (14)..(14)
<223> other groups or atoms, Z1 and Y', as described on p. 17-18 of the application

<400> 1
Xaa Cys Ala Xaa Xaa Xaa Xaa Xaa Leu Val Trp Cys Xaa Xaa 
1               5                   10              


<210> 2
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> peptide portion of compound

<220> 
<221> VARIANT
<222> (1)..(1)
<223> Represents a single covalent bond, or a trifunctional amino acid such as diamino-carboxylic acid 
         
<220> 
<221> MOD_RES
<222> (1)..(1)
<223> other groups or atoms, Z2 and Y', as described on p. 17-18 of the application

<220> 
<221> VARIANT
<222> (2)..(2)
<223> represents an amino acid, a dicarboxylic acid, or a peptide moiety represented by formula (9a) on p. 17 of the application

<220>
<221> DISULFID
<222> (3)..(13)
<223>

<220> 
<221> VARIANT
<222> (5)..(9)
<223> Each independently represent an amino acid 

<220> 
<221> VARIANT
<222> (14)..(14)
<223> Represents an amino acid, or a peptide moiety represented by formula (9b) on p. 17 of the application

<220> 
<221> MOD_RES
<222> (14)..(14)
<223> P-Y-S as defined in item 1


<400> 2
Xaa Xaa Cys Ala Xaa Xaa Xaa Xaa Xaa Leu Val Trp Cys Xaa 
1               5                   10                  


<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Fc-III-FAM, as shown on p.128 of the application

<220>
<221> DISULFID
<222> (2)..(12)
<223>

<220> 
<221> MOD_RES
<222> (13)..(13)
<223> FAM label, as shown on p. 128 of the application

<400> 3
Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr
1               5                   10              